DNER and breast cancer: Several studies have revealed that BET proteins facilitate chromatin remodeling and transcriptional adaptation necessary for establishing the DTP state in response to MEK and PI3K inhibitors in breast cancer models, which can be prevented by the BET inhibitor JQ1 [66,74].